MTE #18: Management of Hepatorenal Syndrome–Acute Kidney Injury in Liver Transplant Candidates (Ticketed)

Nov 17 2024
Convention Center: Room 28 E
7:00 AM - 7:45 AM
Ticketed Event

World Class Speakers

Shilpa Junna, MD
Discussion Leader

Shilpa Junna, MD

Cleveland Clinic Foundation
Pratima Sharma, MD, MS
Discussion Leader

Pratima Sharma, MD, MS

University of Michigan Medical Center

Description

Experts review the diagnosis, prognosis, and management of hepatorenal syndrome–acute kidney injury (HRS-AKI). Topics include the role of biomarkers in the diagnosis of HRS-AKI, and pharmacologic and nonpharmacologic treatment options in liver transplant candidates.  

Journey Maps

Presentations

4:58 PM - 4:58 PM
Nov 17 2024
San Diego, CA

Management of Hepatorenal Syndrome–Acute Kidney Injury in Liver Transplant Candidates

Pratima Sharma, MD, MS, Discussion Leader
Transplant
4:58 PM - 4:58 PM
Nov 17 2024
San Diego, CA

Diagnosis of Acute Kidney Injury and Nonpharmacologic Management in Liver Transplant Candidates

Shilpa Junna, MD, Discussion Leader
Transplant

Objectives

  • Review the updated definitions of HRS-AKI.
  • Describe the role of biomarkers in the diagnostic algorithm of HRS-AKI.
  • Discuss the pharmacologic and nonpharmacologic management of HRS-AKI.